Product category:
Other analytical instruments
News Release from: Bruker BioSpin | Subject: 19F CryoProbe
Edited by the Laboratorytalk Editorial
Team on 11 September 2006
Increased sensitivity for protein drug
screening
Ideal for protein binding studies in drug screening, this cryogenically cooled NMR probe observes fluorine tags an order of magnitude faster than conventional probes
Bruker BioSpin introduces a novel 19F CryoProbe for the company's 500 and 600MHz NMR systems Ideal for protein binding studies in drug screening, this cryogenically cooled NMR probe observes fluorine tags an order of magnitude faster than conventional probes as a result of significantly higher sensitivity
This article was originally published on Laboratorytalk on 14 Aug 2006 at 8.00am (UK)
Related stories
World's highest field actively-shielded NMR magnet
At the Experimental NMR Conference (ENC), Bruker BioSpin announces the 950 US2 - the world's first actively-shielded 950MHz superconducting magnet
Increased sensitivity of in-vivo animal imaging
Bruker BioSpin's pioneering CryoProbe technology has now been implemented for in-vivo animal MRI at 9.4 Tesla
The 19F CryoProbe's ability to observe binding activity faster and with smaller quantities delivers a valuable tool to pharmaceutical and biotechnology companies working on protein drug development.
Bruker BioSpin is the pioneer in the development of cryogenically cooled probes, which improve the signal-to-noise ratio by of 300% to 400% for high-resolution NMR applications.
With this new CryoProbe, 19F spectra with sample concentrations as low as 10-20uM can be acquired in less than 5 minutes.
The probe is configured with proton decoupling capabilities.
"The improvements obtained with our new Fluorine CryoProbe reflect the excellent performance level that we achieve with our CryoProbes" explains Oskar Schett, managing director of Bruker Biospin in Switzerland.
"Having the experience of over 400 systems installed worldwide helps us to push even further the technical limits thus allowing our customers to obtain more and better results with less sample amount in a shorter time.
"The ability to observe fluorine with the NMR CryoProbe provides many exciting new possibilities for NMR binding studies and metabonomics applications," explained Werner Maas, vice president of research and development for Bruker BioSpin.
"With the addition of this new probe, we now offer a CryoProbe for most high-resolution NMR applications.".
• Bruker BioSpin: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
